These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 23077936)

  • 1. [Some aspects of viral hepatitis B and C. Observations on patients treated in Bacau County, between 2007 and 2010].
    Petraru C; Balan G
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):452-6. PubMed ID: 23077936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.
    Villa E; Grottola A; Buttafoco P; Colantoni A; Bagni A; Ferretti I; Cremonini C; Bertani H; Manenti F
    Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.
    Haga Y; Kanda T; Sasaki R; Nakamura M; Nakamoto S; Yokosuka O
    World J Gastroenterol; 2015 Dec; 21(46):12989-95. PubMed ID: 26675364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from Taiwan.
    Huang JF; Yu ML; Lee CM; Dai CY; Hou NJ; Hsieh MY; Wang JH; Lu SN; Sheen IS; Lin SM; Chuang WL; Liaw YF
    Aliment Pharmacol Ther; 2007 May; 25(9):1029-37. PubMed ID: 17439503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the real prevalence of the D virus infection in chronic hepatitis and liver cirrhosis in Romania?
    Grigorescu M; Pascu O; Acalovschi M; Radu C
    Rom J Gastroenterol; 2003 Sep; 12(3):179-82. PubMed ID: 14502316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.
    Giannousis IP; Papatheodoridis GV; Deutsch MJ; Manolakopoulos SG; Manesis EK; Koskinas JS; Archimandritis AJ
    Eur J Gastroenterol Hepatol; 2010 Feb; 22(2):172-9. PubMed ID: 19738477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A report from the Chinese National Fourteenth Symposium on Viral Hepatitis and Liver Diseases].
    Zhu HM; Zhang DZ
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):636-7. PubMed ID: 19719931
    [No Abstract]   [Full Text] [Related]  

  • 11. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of chronic viral hepatitis: achievements and prospects].
    Golovanova EV
    Eksp Klin Gastroenterol; 2012; (6):3-12. PubMed ID: 23402185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients].
    Nicolardi E; Grieco A; Rapaccini GL; Pompili M
    G Ital Nefrol; 2010; 27(3):262-73. PubMed ID: 20540019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy.
    Giannini EG; Marenco S; Fazio V; Pieri G; Savarino V; Picciotto A
    Liver Int; 2012 Aug; 32(7):1113-9. PubMed ID: 22471814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M; Ken A; Okuno T
    Cancer; 1999 May; 85(9):1943-50. PubMed ID: 10223234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV genotype 1 is almost exclusively present in Romanian patients with chronic hepatitis C.
    Grigorescu M;
    J Gastrointestin Liver Dis; 2009 Mar; 18(1):45-50. PubMed ID: 19337633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current issues in antiviral therapy of chronic hepatitis B and C].
    Bakulin IG
    Eksp Klin Gastroenterol; 2010; (5):3-9. PubMed ID: 20731128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence of chronic hepatitis B virus (HBV) infection in closed communities and risk behaviour].
    Nazare C; Gîrleanu I; Cojocariu-Salloum C; Trifan A
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):325-30. PubMed ID: 21870718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems and prevention of viral hepatitis in Thailand.
    Poovorawan Y; Chongsrisawat V; Tangkijvanich P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S18-25. PubMed ID: 11529332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of chronic hepatitis B and C - update 2010].
    Mertens JC; Geier A; Müllhaupt B
    Praxis (Bern 1994); 2010 Aug; 99(17):1015-28. PubMed ID: 20737393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.